DOCSLIB.ORG

Muhamad Zulhanif Bin Mat Harun 940610-11-5849 Cm071022

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Muhamad Zulhanif Bin Mat Harun 940610-11-5849 Cm071022 MUHAMAD ZULHANIF BIN MAT HARUN 940610-11-5849 CM071022 What is birth control? 'Birth control' is a term that describes things that stop a woman or girl from becoming pregnant, or giving birth. Birth control can mean a wide range of things ± from 'contraceptives' (used to reduce the chances of a woman becoming pregnant) to other ways of avoiding pregnancy, like not having sex. Contraception Are there many different methods of contraception? Yes. Contraceptives work by preventing a man¶s sperm from fertilising a woman¶s egg, and this can be done in several different ways. There are two main types of contraception: y Barrier methods - which physically prevent sperm from swimming into the uterus and fertilising the woman¶s egg y Hormonal methods - which alter a woman¶s hormonal cycle to prevent fertilisation. These are the main types of contraception that are generally used by teenagers. Condoms for sale in a Chicago pharmacy Other types of contraception, which are generally not used by young people, include natural methods such as only having sex at certain times of the month (these are often not effective enough), and sterilization, which is a permanent surgical procedure. The intrauterine device (IUD) and intrauterine system (IUS), also known as 'the coil', are generally not used by young people although in some countries, such as the UK, they are now considered suitable for all age groups. Barrier methods of contraception There are three main barrier methods of contraception used by teens: the male condom, the female condom, and spermicides in the form of foams or gels. The male condom Condom The male condom is the only method of contraception that boys can use. It's really just a rubber tube. It's closed at one end like the finger of a glove so that when a boy puts it over his penis it stops the sperm going inside a girl's body. An advantage of using male condoms is that a boy can take an active part in using contraception ± it's not just the girl's responsibility. The female condom female condom The female condom is not as widely available as the male condom and it is more expensive. It is however very useful when the man either will not, or cannot, use a male condom. It¶s like a male condom, except it¶s bigger and worn inside the vagina. It's a good idea to practice with condoms before having sex. You can get used to touching them, and it might help you feel more confident about using them when you do have sex. Spermicides Spermicides are chemical agents that both kill sperm and stop sperm from travelling up into the cervix (the lower part of the uterus, or womb, where babies develop). Spermicides come in different forms including creams, foaming tablets, gels and foam (which is squirted into the vagina using an applicator). Young people who use spermicide mostly choose foam. Spermicides are not very effective against pregnancy when used on their own, but are very effective if used at the same times as a male condom. When used together, the male condom and spermicide can be a great combination for effectively protecting against both pregnancy and sexually transmitted diseases such as HIV. Some condoms also come lubricated with spermicide (Nonoxynol 9). A spermicidal lubricant aims to provide an additional level of protection if some semen happens to leak out of the condom. This can help to reduce the likelihood of pregnancy, but regular use of Nonoxynol 9 can cause an allergic reaction in some people resulting in little sores that can actually make the transmission of HIV and other sexually transmitted infections more likely. Nonoxynol 9 is only a suitable spermicide for a woman who is HIV-negative, and whose partner does not have HIV either. It should only be used for vaginal sex. Hormonal methods of contraception There are two main types of hormonal contraceptive which can be used by teens: the contraceptive pill, and the injectable hormonal contraceptive. If used properly, both are extremely effective in providing protection against pregnancy ± but they provide no protection at all against sexually transmitted diseases. For very good protection against both pregnancy and sexually transmitted diseases like HIV, a hormonal method should be used at the same time as the male condom. In some countries, contraceptive patches (that stick to the skin) and rings (that go inside the vagina) are also available. The contraceptive pill (sometimes known as the birth control pill) contraceptive pill y What does 'going on the pill' mean? People often talk about being 'on the pill'. This means they are using the oral contraceptive pill as a method of contraception. This has nothing to do with oral sex, and just means that the contraceptive is in pill form which is taken orally (swallowed). y How does it work? The pill contains chemicals called hormones. One type of pill called µthe combined pill¶ has two hormones called Oestrogen and Progestogen. The combined pill stops the release of an egg every month ± but doesn't stop periods. The other type of pill only has Progestogen in it. It works by altering the mucous lining of the vagina to make it thicker. The sperm cannot then get through, and as the sperm can't meet the egg, the girl can't get pregnant. y What do you do? Usually a girl has to take one pill every day for about three weeks. She then takes a break for seven days while she has her period, before starting the cycle again (or instead, she may take µsugar¶ pills for those seven days, i.e. pills that don¶t actually have any affect, but which are taken purely so she keeps in the routine) for seven days. It's very important not to forget to take these pills. If this happens, protection against pregnancy is lost. The Progestogen-only pill also has to be taken at the same time every day. y How effective is the pill? It's a very effective method of contraception if it is taken correctly. If the pill is taken exactly according to the instructions, the chance of pregnancy occurring is practically nil. But if a girl forgets a pill, or is very unwell, its effectiveness is reduced. Another disadvantage of the pill is that it does not provide any protection against STDs. For very good protection against both pregnancy and STDs, the birth control pill should be used at the same time as the male condom. Sperm bank The development of sperm banks, whilst considered by some to be controversial, has enabled people to have greater control over their reproductive lives. By providing sperm from donors who are checked and screened, thousands of women every year are able to bear their own children in circumstances where this might otherwise not be possible. Controversy stems from the fact that donors effectively father children for others, often in considerable numbers, and usually take no part in the upbringing of such children, and also from the fact that single women and coupled lesbians frequently use sperm banks in order to have their own biological children. Storage The sperm is stored in small vials or straws of holding between 0.4 and 1.0 ml and cryogenically preserved in liquid nitrogen tanks. It has been proposed that there should be an upper limit on how long frozen sperm can be stored, however a baby has been conceived in the UK using sperm frozen for 21 years[1]. Before freezing, sperm may be prepared so that it can be used for intra-cervical insemination (ICI), intrauterine insemination (IUI) or for IVF(or Use Sperm supplied by a sperm bank may be used where a woman's partner is infertile or where he carries genetic disease. Increasingly, donor sperm is used to achieve a pregnancy where a woman has no male partner, including among lesbian and bisexual mothers-to-be. Sperm from a sperm donor may also be used in surrogacy arrangements and for creating embryos for embryo donation. Donor sperm may be supplied by the sperm bank directly to the recipient to enable a woman to perform her own artificial insemination which can be carried out using a needle-less syringe or a cervical cap conception device. The cervical cap conception device allows the donor semen to be held in place close to the cervix for between six to eight hours to allow fertilization to take place. Alternatively, donor sperm can be supplied by a sperm bank through a registered medical practitioner who will perform an appropriate method of insemination or IVF treatment using the donor sperm in order for the woman to become pregnant. From a medical perspective, a pregnancy achieved using donor sperm is no different from a pregnancy achieved using partner sperm, and it is also no different from a pregnancy achieved by sexual intercourse. Sperm banks may supply other sperm banks or a fertility clinic with donor sperm to be used for achieving pregnancies. Sperm banks may also supply sperm for research or educational purposes. In countries where sperm banks are allowed to operate, the sperm donor will not usually become the legal father of the children he produces as the result of the use of the sperm he donates, but he will be the 'biological father' of such children. In cases of surrogacy involving embryo donation, a form of 'gestational surrogacy', the 'commissioning mother' or the 'commissioning parents' will not be biologically related to the child and may need to go through an adoption procedure. As with other forms of third party reproduction, the use of donor sperm from a sperm bank gives rise to a number of moral, legal and ethical issues.
Load more

Recommended publications
  • 1008-475 Artwork, the Stork OTC Product Information Leaflet, 8.5X11
    The Stork® OTC Conception Device Where to Purchase For information on where to purchase, please visit • Available without a prescription our website at www.storkotc.com and click “Shop • Assist conception in the privacy of home Now” for a full list of retailers. You can also purchase direct from our website. • Cost-effective: a cost alternative to more invasive, costly, in-clinic treatments Available online and in-store at select retailers: • Easy to use: 3 simple steps Testimonials Complete Instructions for Use are provided with The Stork OTC device. Please read these carefully prior to use. For a video version of the instructions, please visit our website at: www.storkotc.com. Questions? “My wife and I got married while I was in the Army and between my deployments and careers we ended up waiting until our we were almost Always speak to your Healthcare Professional if you 40 to try to start a family. We both had a lot of concerns about our ability to conceive but fortunately the Stork was available. We were able have any concerns or questions about your fertility to use it in the privacy of our own home and after only two tries, we or health in general. conceived. We’re 6 months along now and we couldn’t be happier!” – A.K.Z., US If you have any questions relating to The Stork OTC, please contact Customer Service at “Thank you!!! After over a year of trying to conceive and finding out husband had a few sperm related issues, we got pregnant on our second [email protected] or by phone at 1.412.200.7996.
    [Show full text]
  • 1 United States District Court Eastern District Of
    2:16-cv-11810-MAG-RSW Doc # 10 Filed 06/08/16 Pg 1 of 24 Pg ID 95 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION CONCEIVEX, INC., ) ) Plaintiff, ) ) JURY TRIAL DEMANDED v. ) ) Case No. 16-cv-11810 RINOVUM WOMEN’S HEALTH, ) Hon. Mark A. Goldsmith INC., THE STORK IB2C, INC., ) and RINOVUM WOMEN’S ) HEALTH, LLC, ) ) Defendants. ) FIRST AMENDED COMPLAINT FOR PATENT AND TRADEMARK INFRINGEMENT Plaintiff Conceivex, Inc. (“Conceivex”), for its Complaint against Defendants, alleges as follows: Nature Of Action, Parties, and Jurisdiction 1. This is a civil action for patent infringement under the Patent Laws, 35 U.S.C. 1 et seq., for trademark infringement and false designation of origin under the Lanham Act, 15 U.S.C. §§ 1051 et seq., for deceptive trade practices under Michigan statutory law; and for unfair competition and trademark infringement under Michigan common law. 1 2:16-cv-11810-MAG-RSW Doc # 10 Filed 06/08/16 Pg 2 of 24 Pg ID 96 2. This Court has subject matter jurisdiction of this action under 28 U.S.C. §§ 1331, 1338, and 1367. The matter in controversy exceeds the sum of $75,000, exclusive of interests and costs. 3. Conceivex is a Michigan corporation with its principal place of business at 4111 Andover Road West, Bloomfield Hills, MI 48302. (Conceivex’s former principal place of business was at 5 East Main Street, Saranac, MI 48881.) Conceivex is a leader in assisting couples to overcome difficulties in conceiving. It offers the CONCEPTION KIT at-home fertility system. 4. On information and belief, Defendant Rinovum Women’s Health, Inc.
    [Show full text]
  • The Stork® OTC Expands to More Retailers Nationwide
    PRESS RELEASE CONTACT: Brianna Clements 724-241-8936 [email protected] Leslie Swiantek 724-880-1122 [email protected] The Stork® OTC Expands to More Retailers Nationwide The first and only conception assistance device cleared by the FDA for home use without a prescription is now available at select Target stores nationwide PITTSBURGH, Pa., June 13th, 2017– Rinovum Women's Health announced today that The Stork ® OTC – the only FDA-cleared over-the-counter device designed to optimize the chances of at-home conception – is now available for purchase in 1,292 Target stores across the United States. The Stork OTC is also available at major pharmacy chains nationwide. Using the cervical cap insemination technique, The Stork® OTC offers a safe, easy-to- use treatment option for couples trying to build a family naturally in the privacy of their own home. The Stork OTC is a uniquely designed medical device that uses a condom-like sheath to deliver sperm as closely as possible to the cervical opening. The cervical cap insemination technique has up to a 20% success rate. This innovative alternative can be especially helpful for the 7.3 million people in the U.S. experiencing difficulty conceiving due to infertility1. “The Stork OTC is a safe option for couples facing challenges with infertility,” said Stephen Bollinger, Rinovum President and CEO. “It’s an easy-to-use, drug-free, cost- effective way to assist your chances to conceive a child.” This type of treatment has been used effectively in the professional setting, but now it’s readily available to couples at home.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8.454.493 B2 La Vean (45) Date of Patent: Jun
    USOO8454493B2 (12) United States Patent (10) Patent No.: US 8.454.493 B2 La Vean (45) Date of Patent: Jun. 4, 2013 (54) CONCEPTION DEVICE AND RELATED 3,037,508 A 6, 1962 Friedman METHODS 3,371,664 A 3, 1968 Pleshette 3,952,737 A 4/1976 Lipfert et al. ck (75) Inventor: Michael LaVean, Saranac, MI (US) :33; A t Styal. 128,832 4,200,090 A 4, 1980 Drobish (73) Assignee: Conceivex, Inc., Saranac, MI (US) 4,200,091 A 4, 1980 Del Conte 4,219,016 A 8, 1980 Drobish et al. (*) Notice: Subject to any disclaimer, the term of this 1895; A RE: s h etal patent is extended or adjusted under 35 4,311,543- W I A 1/1982 StrickmanOS et3. al. U.S.C. 154(b) by 306 days. 4,320,751 A 3, 1982 Loeb (21) Appl. No.: 12/815,003 (Continued) 22) Filed Jun. 14, 2010 FOREIGN PATENT DOCUMENTS (22) Filed: un. 14, WO WO99.36O10 7, 1999 O O WO WO 99.37259 7, 1999 (65) Prior Publication Data WO WO 2006/0584.09 8, 2006 Related U.S. Application Data International Search Report and Written Opinion of the International (63) Continuation-in-part of application No. 1 1/692,511, Saching Authority for International Application No. PCT/US2008/ filed on Mar. 28, 2007, now abandoned. 000505: Mailing date Jun. 20, 2008. (Continued) (51) Int. Cl. A6B 7/2425 (2006.01) Primary Examiner — Charles A Marmor, II (52) S.C. 6OO/33 Assistant Examiner — Catherine E Burk ... T. grgrrr.
    [Show full text]
  • Equity Research [email protected]
    October 5, 2010 Jason Napodano, CFA 312-265-9421 Equity Research [email protected] www.zacks.com 111 North Canal Street, Chicago, IL 60606 INVO Bioscience (IVOB-OTC) IVOB: INVOcell Launched In Canada UPDATE Through Exclusive Agreement This morning INVO Bio announced its INVOcell device has been launched in Canada through an exclusive distribution agreement with Invaron Pharma. We see this as a significant near-term opportunity for the company. Outperform Current Recommendation The INVOcell device has been elegantly designed to Prior Recommendation N/A provide several advantages when compared to Date of Last Change 05/24/2010 interuterine insemination (IUI) or in vitro fertilization (IVF). These advantages include lower risk of ovarian Current Price (10/05/10) $0.08 hyperstimulation syndrome, lower risk of anesthesia complications, and wider applicability and availability for Target Price $0.25 infertile couples. New reimbursement policies in Canada should help drive uptake of INVOCell over the next several years. SUMMARY DATA 52-Week High $0.51 Risk Level Above Average 52-Week Low $0.03 Type of Stock Small-Growth One-Year Return (%) -83.80 Industry Med-Biomed/Gene Beta -0.96 Zacks Rank in Industry 45 of 138 Average Daily Volume (sh) 121,134 ZACKS ESTIMATES Shares Outstanding (mil) 63 Market Capitalization ($mil) $3 Revenue (in millions of $) Short Interest Ratio (days) N/A Q1 Q2 Q3 Q4 Year Institutional Ownership (%) N/A Insider Ownership (%) N/A (Mar) (Jun) (Sep) (Dec) (Dec) 2009 0.04 A 0.02 A 0.00 A 0.01 A 0.06 A Annual Cash Dividend $0.00 2010 0.02 A 0.01 A 0.02 E 0.02 E 0.07 E Dividend Yield (%) 0.00 2011 0.10 E 2012 0.16 E 5-Yr.
    [Show full text]
  • The Stork Ib2c, Inc, a Rinovum Women's Health Company
    PRESS RELEASE – DRAFT CONTACT: Brianna Clements, The Stork Ib2C, Inc, A Rinovum Women’s Health Company 724-241-8936 [email protected] The Stork Ib2C, Inc, A Rinovum Women’s Health Company, Bridging the Gap for Women With Limited Access to Fertility Services and Local Clinics The Stork® OTC offers solution to findings revealed in a recent study showing reproductive-age women need better access to at-home fertility treatment options PITTSBURGH, Pa., April 19, 2017– While fertility clinics may be difficult for some women to access, there are other more accessible options. Pittsburgh-based medical device company, Rinovum Women's Health, offers solutions for building families naturally with an at-home conception device designed to help with becoming pregnant. This innovative alternative can be especially helpful for the nearly 40 percent of reproductive-age women in the United States with limited or no local access to assisted reproductive technology clinics. The Stork® OTC (www.storkotc.com) is an FDA-cleared over-the-counter treatment device designed to optimize the chances of at-home conception using the cervical cap insemination technique. It is a safe, easy-to-use, accessible treatment option to help women become pregnant during ovulation without a prescription and in the privacy of their own home. According to a recent study published in the journal Fertility & Sterility, 25 million reproductive-age women in the United States have limited or no access to assisted reproductive technology (ART) clinics, which provide services that are vital to many women trying to become pregnant. The study used data from the Centers for Disease Control and Prevention to pinpoint infertility clinics in proximity to where women live in order to evaluate and assess viable access to infertility care in the United States.
    [Show full text]
  • Bharathiar University
    DEVELOPMENTAL BIOLOGY AND HUMAN WELFARE M.Sc Zoology II YEAR BHARATHIAR UNIVERSITY COIMBATORE – 641046 SCHOOL OF DISTANCE EDUCATION 1 2 DEVELOPMENTAL BIOLOGY AND HUMAN WELFARE TABLE OF CONTENTS UNIT TITLE PAGES I GAMETOGENESIS 4 II FERTILIZATION PROCESS 30 III EMBRYOGENESIS 43 IV EMBRYONIC INDUCTION 73 V HUMAN WELFARE 105 3 UNIT I GAMETOGENESIS Sexual reproduction involves the formation of male and female gametes and the mechanisms necessary for the gametes to come together and fuse to form one cell that represents the beginning of a new individual with a distinct genetic identity. Preparation for pregnancy involves two main programs of events: The process of formation of the male and female gametes occurs in the gonads (ovary or testis). SPERMATOGENESIS 1.0 INTRODUCTION 1.1 STRUCTURE OF THE GERMINAL EPITHELIUM 1.2 DEVELOPMENTAL STAGES OF SPERMATOGENESIS 1.3 THE TEMPORAL COURSE OF SPERMATOGENESIS 1.4 SPERMATOCYTOGENESIS 1.5 LOCAL COURSE OF SPERMATOGENESIS - THE SPERMATOGENESIS WAVE 1.6 SPERMIOGENESIS (SPERMATOHISTOGENESIS) AND STRUCTURE OF THE SPERM CELL 1.7 LEYDIG'S INTERSTITIAL CELLS AND HORMONAL REGULATION 1.0 INTRODUCTION Spermatogenesis is initiated in the male testis with the beginning of puberty. This comprises the entire development of the spermatogonia (former primordial germ cells) up to sperm cells. The gonadal cords that are solid up till then in the juvenile testis develop a lumen with the start of puberty. They then gradually transform themselves into spermatic canals. They are termed convoluted seminiferous tubules (Tubuli seminiferi contorti) and are so numerous and thin that in an adult male testicle. They are coated by a germinal epithelium that exhibits two differing cell populations: some are sustentacular cells (= Sertoli's cells) and the great majority of the germ cells in various division and differentiation.
    [Show full text]
  • The FERTI·LILY Conception Cup Increases the Chance of Conceiving in Comparison with Expected Pregnancy Rates: a Prospective Observational Study
    Journal of Pregnancy and Newborncare ISSN: 2688-7487 Research Article The FERTI·LILY Conception Cup Increases the Chance of Conceiving in Comparison with Expected Pregnancy Rates: A Prospective Observational Study This article was published in the following Scient Open Access Journal: Journal of Pregnancy and Newborncare Received 29 March 2021; Accepted 12 April 2021; Published 14 April 2021 1 2 Grada van den Dool , Gonnie van Osta and Abstract Maarten Wiegerinck3* 1Nij Linge, Kinderwenscentrum, Gorinchem, 4207 Background: With the average age of first-time mothers increasing over the last HG, The Netherlands decades in the Western countries, difficulties to conceive naturally are rising in parallel. 2Data Analysis and Medical Writing, Hilversum, The FERTI·LILY Conception Cup (FCC) is a medical device designed to stimulate natural 1213AP, The Netherlands conception. The aim of the current study was to evaluate the safety, efficacy, and user 3Wiegerinck Consultancy, Eindhoven, 5613CJ, The feasibility of the FCC. Netherlands Material and methods: 85 female volunteers trying to conceive entered the prospective, 1-arm, open label, non-randomized, observational study and were followed-up for maximally 3 months. The pregnancy rate observed in the study was compared to the pregnancy expectation based on 2 prognostic models to determine the device’s efficacy. Through questionnaires, information about safety, pregnancy, and user feasibility was collected. Results: Of the 85 study participants, 65 used the product as instructed throughout the study. No Adverse Events (AEs) were reported. 23 participants conceived during the study, resulting in an overall pregnancy rate of 35.4% in the population that completed the study according to protocol, in contrast to the predicted rate of 23.9% (p < 0.05).
    [Show full text]
  • Male and Female Infertility: Causes, and Management
    IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 18, Issue 9 Ser.13 (September. 2019), PP 27-32 www.iosrjournals.org Male and Female Infertility: Causes, And Management Murtaza Mustafa!, AM,Sharifa2,Janan Hadi3,EM.IIIzam4,,S.Aliya5, 1,3, Faculty of Medicine and Health Sciences, UniversityMalaysia,Sabah,KotaKinabalu,Sabah,Malaysia. 2. Quality Unit Hospital Queen Elizabeth,KotaKinabalu,Sabah,Malaysia 4, Poly Clinic Sihat,Likas,KotaKinabalu,Sabah,Malaysia 5,MedicalCollege,ZiauddinUniversity,Karachi,Pakistan * Corresponding Author:Murtaza Mustafa Abstract:Infertility is a common problem worldwide. Childlessness could be male infertility,femaleinfertility or combined infertility. Infertility has psychological and social impact. Female infertility is due to ovulatory problem, in male semen quality, and idiopathic cause. Sexually transmitted disease (STD), genetic, diabetes, pituitary factors, and toxins also play and importantrole.Diagnosisinclude, semenanalysis, for male, female partner tested for hormonal para meters,e.g.,FSH,TSH, abnormal levels indication of infertility. If the conservative medical treatment fail, physician my advice the patient to undergo in-vitro fertilization(IVF),and assisted reproductive technology (ART).IVF has promising results. Keywords:Infertility,Causes, Psychological and social impact,Treatment. --------------------------------------------------------------------------------------------------------------------------------------- Date of Submission: 12-09-2019
    [Show full text]
  • DRAFT-1008-245 the STORK OTC FAQS Customer
    PG.1 Frequently Asked Questions Is there clinical data on the Stork OTC? Can I use The Stork OTC without using the condom? Are there any known complications with or adverse reactions to using the device? A post coital study (peer-reviewed and published in Surgical Technology International XXVII) demonstrates on The Stork OTC can be used without the condom, but should not be used with another condom other than the one There are no publications that discuss whether cap usage can cause TSS (toxic shock syndrome). The Instructions Has the product been evaluated by the FDA? average a 3.23 higher value of sperm concentration at the cervix with the Stork OTC compared to the value of sperm provided. Please read the instructions leaflet provided with the device for details on how to use without the condom. for Use instruct the user to remove the cap four to six hours after insertion to reduce the risk of TSS. The risk of Yes, the Stork OTC received FDA over-the-counter clearance in July of 2014 (K140186). The product is available to concentration with natural intercourse, for 85% of study participants. The remaining 15% of subjects saw no change Toxic Shock Syndrome (TSS) exists for products like tampons and other vaginal devices. TSS is a rare but serious purchase without a prescription at multiple retailers. For a full list of retailers visit in sperm concentration between the Stork OTC and natural intercourse. Can I use a regular condom with the applicator provided? disease that may cause death. Warning signs of TSS include sudden fever (usually 102° F or more) and vomiting, http://www.storkotc.com/where-to-buy/ Use only the Conceptacle (the condom-like sheath with the cervical cap inside) provided in the Stork OTC packaging.
    [Show full text]
  • Equity Research [email protected]
    November 23, 2010 Jason Napodano, CFA 312-265-9421 Equity Research [email protected] www.zacks.com 111 North Canal Street, Chicago, IL 60606 INVO Bioscience (IVOB-OTC) IVOB: Disappointing Third Quarter, But UPDATE Signs Point To Better Times Ahead INVO Bio reported disappointing third quarter financial results. The company did not record any sales of its INVOcell device during the quarter due to funding issues and assembly delays at the manufacturer. Both issues Outperform Current Recommendation have been worked out and orders placed during the third Prior Recommendation N/A quarter were shipped in mid-October 2010. Although Date of Last Change 05/24/2010 sales of the INVOcell device have been low, the clinical data begin generated by post-approval marketing studies Current Price (11/23/10) $0.06 around the world has been impressive. Data flow should improve over the next several quarters, and thus we Target Price $0.20 believe sales will start to trend higher. Priority number one for management is to secure funding over the near-term for operations and the filing of the U.S. 510(k) application. SUMMARY DATA 52-Week High $0.43 Risk Level Above Average 52-Week Low $0.03 Type of Stock Small-Growth One-Year Return (%) -83.78 Industry Med-Biomed/Gene Beta -0.86 Zacks Rank in Industry 23 of 138 Average Daily Volume (sh) 70,514 ZACKS ESTIMATES Shares Outstanding (mil) 63 Market Capitalization ($mil) $4 Revenue (in millions of $) Short Interest Ratio (days) N/A Q1 Q2 Q3 Q4 Year Institutional Ownership (%) N/A Insider Ownership (%) N/A (Mar) (Jun) (Sep) (Dec) (Dec) 2009 0.04 A 0.02 A 0.00 A 0.01 A 0.06 A Annual Cash Dividend $0.00 2010 0.02 A 0.01 A 0 A 0.02 E 0.05 E Dividend Yield (%) 0.00 2011 0.10 E 2012 0.16 E 5-Yr.
    [Show full text]
  • Artificial Insemination Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022
    Aug 08, 2017 23:34 EDT Artificial Insemination Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022. According to Stratistics MRC, the Artificial Insemination Market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Changing lifestyle and growing focus of modern women regarding Planned Parenthood due to uninterrupted full time career are some of the key factors anticipated to drive the growth of the global artificial insemination market. Moreover, factors such as cost efficiency in comparison to other fertilization procedures and rising cases of male infertility are the other factors that could boost the market. However, the market is facing some of challenges which include safety issues, ethical concerns, and high risk of transmission of sexual transmitted diseases. Amongst end users, home based segment is expected to grow at a high CAGR after hospital and fertility centers due to availability of various easy to use kits in the market. Asia Pacific holds the largest share in the global market and is expected to grow which can be attributed to increasing disposable income and awareness amongst the population. Some of the key players in this market include Bescot Healthcare, Hi-Tech Solutions, Church & Dwight Co. Inc., Conceivex Inc, Rinovum Women's Health LLC (US), TenderNeeds Fertility, Pride Angel, Clearblue, Insemination Supplies, LLC, The Stork Ib2C, Inc., Kate & Duck and Boots Pharmaceuticals. For More, Please Visit: http://www.strategymrc.com/report/artificial-
    [Show full text]